Skin Cancer Home > DTIC

As a type of chemotherapy drug, DTIC-Dome® (dacarbazine) is prescribed to treat malignant melanoma that has spread to other areas of the body (metastasized). It is also approved for use in combination with other medications to treat Hodgkin's disease. It comes as an injection that is given into a vein once a day for 5 to 10 days, followed by a break in treatment.
When undergoing therapy with DTIC-Dome, you should understand the potential risks associated with this medicine. For example, this medication may not be safe for use in people with certain allergies or those taking certain medications or herbal supplements. Also, people who have kidney disease, liver disease, or other medical issues should discuss whether DTIC-Dome is an appropriate medicine for their situation.
(Click DTIC-Dome for a closer look at this chemotherapy drug, including an explanation of how the drug works and a list of helpful dosing tips.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):



Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.